Biologic therapy has brought reprieve from pain and inflammation and escape from permanent joint damage to thousands of Canadians with rheumatoid arthritis (RA). Hear from doctors, patients, payers, researchers, regulators and manufacturers about what the future in Alberta holds for these expensive genetically engineered agents in fighting RA.
When: Attend the symposium May 29, 9 a.m. to 5 p.m.
Where: The Westin Hotel, Edmonton. Hosted by the Institute of Health Economics.
Free and open to the public. But you must register.